Bacillus coagulans 관련 Irritable Bowel Syndrome (IBS)

Q: Does Bacillus coagulans help with Irritable Bowel Syndrome (IBS)?

Based on 3 studies with 400 participants, there is moderate evidence from clinical studies that Bacillus coagulans may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).

Q: How much Bacillus coagulans should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 1-2 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Bacillus coagulans?

Reported side effects may include Mild gas during initial use (generally less than other probiotics due to spore form), Occasional bloating, Rare loose stools. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Bacillus coagulans and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbacillus\u002Dcoagulans\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

Key Study Findings

Meta-Analysis

Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome.

Dose: None vs: placebo Outcome: improvement in key IBS symptoms 효과: None None

대상 집단: patients with IBS from 32 RCTs evaluating 10 probiotic strains

Randomized Controlled Trial n=61 4 weeks Double-blind

Effects of a Bacillus subtilis HU58 and Heyndrickxia faecalis SC208 spore-forming probiotic formula on gastrointestinal …

Dose: None vs: Placebo Outcome: Abdominal pain (NRS) and stool consistency (BSFS) 효과: None P = 0.003 (pain); P = 0.035 (s

대상 집단: Adults with diarrhoea-predominant IBS (IBS-D)

Randomized Controlled Trial n=100 12 weeks

Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, …

Dose: None vs: Control Outcome: Pain outcomes 효과: None P < .001

대상 집단: IBS patients

Meta-Analysis

Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review …

Dose: Various probiotic strains/mixtures vs: Placebo Outcome: Outcome-specific efficacy ranking in IBS 효과: None None

대상 집단: Adults with IBS (RCTs)

Randomized Controlled Trial 12 weeks Double-blind

The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in …

Dose: 20.5% vs: placebo Outcome: IBS symptom improvement 효과: None p = 0.038

대상 집단: Adults with IBS

Review

Oral microbial shift induced by probiotic Bacillus coagualans along with its clinical perspectives.

Dose: None vs: None Outcome: colitis/IBD severity 효과: None None

대상 집단: None

Key Statistics

연구

400

참여자

↑

Positive

등급

Referenced Papers

Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome. Review

Journal of clinical … 2026

Effects of a Bacillus subtilis HU58 and Heyndrickxia faecalis SC208 spore-forming probiotic formula on gastrointestinal health: results of a randomised, … Other

Beneficial microbes 2026

Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial. RCT

Medicine 2024 6 인용

Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Meta-Analysis

Nutrients 2023 33 인용

Oral microbial shift induced by probiotic Bacillus coagualans along with its clinical perspectives. Review

Journal of oral … 2023 12 인용

Effects of Glutamine, Curcumin and Fish Bioactive Peptides Alone or in Combination on Intestinal Permeability in a Chronic-Restraint Stress Model. Other

International journal of … 2023 9 인용

The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel … Other

Journal of clinical … 2023 9 인용

Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT … RCT

Medicine 2021 45 인용

Impact of a Gastrointestinal Stable Probiotic Supplement Bacillus coagulans LBSC on Human Gut Microbiome Modulation. Other

Journal of dietary … 2021 33 인용

Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management? RCT

European journal of … 2020 20 인용

Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel … RCT

Scientific reports 2019 65 인용

Bacillus coagulans and its applications in medicine. Review

Beneficial microbes 2019 45 인용

Bacillus coagulans and its applications in medicine. Other

Beneficial microbes 2019 29 인용

Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, … Other

Food & nutrition … 2018 162 인용

Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled … RCT

Beneficial microbes 2018 59 인용

Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled … RCT

Nutrition journal 2016 102 인용

A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients … RCT

European review for … 2014 33 인용

The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Other

Gastroenterology and hepatology … 2014

Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. RCT

Postgraduate medicine 2009 144 인용

Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. RCT

Methods and findings … 2009 104 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:: 1-2 billion CFU/day
ibssupport:: 2 billion CFU/day (GBI-30 6086 strain)

상한량: Well-tolerated up to 6 billion CFU/day in clinical trials

연구에서 사용된 용량

용량	기간	효과	N
None	--	Positive	--
None	4 weeks	Positive	61
None	12 weeks	Positive	100
Various probiotic strains/mixtures	--	Positive	--
20.5%	12 weeks	Positive	--
None	--	Positive	--
None	--	Mixed	--
None	--	Mixed	--

권장 복용 시간: With meals for optimal spore germination and colonization

Safety & Side Effects

보고된 부작용

⚠ Mild gas during initial use (generally less than other probiotics due to spore form)
⚠ Occasional bloating
⚠ Rare loose stools

알려진 상호작용

● Antibiotics (spore form is more resistant than vegetative probiotics, but spacing still recommended)
● Immunosuppressants (theoretical risk in immunocompromised patients)

일일 최대 섭취 허용량: Well-tolerated up to 6 billion CFU/day in clinical trials

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Bacillus coagulans help with Irritable Bowel Syndrome (IBS)?

Based on 3 studies with 400 participants, there is moderate evidence from clinical studies that Bacillus coagulans may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).

How much Bacillus coagulans should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 1-2 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Bacillus coagulans?

Reported side effects may include Mild gas during initial use (generally less than other probiotics due to spore form), Occasional bloating, Rare loose stools. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Bacillus coagulans and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

한눈에 보기

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

Evidence Strength72%

High confidence

연구 분석

RCT (9)Meta (1)Other (0)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: Irritable Bowel Syndrome (IBS)

자세히 알아보기

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.

Bacillus coagulans 관련 Irritable Bowel Syndrome (IBS)

Embed This Widget

결론

Key Study Findings

Key Statistics

Referenced Papers

Dosage & Usage

일반적으로 사용되는 용량

연구에서 사용된 용량

Safety & Side Effects

보고된 부작용

알려진 상호작용

Frequently Asked Questions

Related Evidence

관련 다른 성분: Irritable Bowel Syndrome (IBS)